Several practical factors may explain fatigue during GLP-1 therapy: Reduced food intake due to appetite suppression can lead to lower energy consumption Gastrointestinal side effects like nausea can be physically draining Adaptation to metabolic changes as your body adjusts to the medication For people with diabetes who take insulin or sulfonylureas (like gliclazide) alongside GLP-1 medications, low blood glucose (hypoglycaemia) may cause fatigue
OConnell earned the esteem of her colleagues by handling the tricky transition of leadership at ABC News just a few months after her role was expanded to encompass the division
PT 141, also known as Bremelanotide, has gained significant attention due to its unique mechanism of action
Skin cells take time to turn over, usually about 28 to 40 days
These aren't perfect they're expensive, require medical supervision, and can have side effects but they're backed by solid science and real results
Experience with oral GLP1 use in diabetes has highlighted this disconnect: tablets are often not viewed as premium products, and the scientific and manufacturing innovation required to enable the oral delivery of biologics can be underappreciated at times reduced to just a pill. This perception gap may pose commercial challenges, especially when oral therapies are priced alongside injectable alternatives